Mullica Hill, NJ, United States of America

Michael A Pratta


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Michael A Pratta

Introduction

Michael A Pratta is a notable inventor based in Mullica Hill, NJ (US). He has made significant contributions to the field of medical research, particularly in the area of graft-versus-host disease. With a total of 4 patents to his name, Pratta's work has the potential to impact treatment modalities for patients at risk of this condition.

Latest Patents

Among his latest patents, Pratta has developed biomarkers that are predictive of a subject's responsiveness to a JAK inhibitor. These biomarkers, compositions, and methods are crucial for selecting appropriate treatment options for individuals who have, are suspected of having, or are at risk of developing graft-versus-host disease. His innovative approach aims to enhance patient outcomes through personalized medicine.

Career Highlights

Michael A Pratta is currently associated with Incyte Corporation, where he continues to advance his research and development efforts. His work at Incyte has positioned him as a key player in the field of biotechnology, focusing on innovative solutions for complex medical challenges.

Collaborations

Pratta collaborates with esteemed colleagues, including Michael D Howell and Hao Liu. These partnerships foster a dynamic research environment that encourages the exchange of ideas and expertise, ultimately leading to groundbreaking advancements in their field.

Conclusion

Michael A Pratta's contributions to the field of medical research, particularly through his patents and collaborations, highlight his commitment to improving patient care. His work exemplifies the importance of innovation in addressing critical health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…